Skip to content

Quick ratio at other companies

Merck & Co. logo
Merck & Co.MRK
1.1×-0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-1.1×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
14.7×+4.6×
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
3.5×-1.1×
HRO
HarrowHROW
2.3×+1.4×
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.1×+8.4×

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Calculated from EyePoint, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's quick ratio?
EyePoint, Inc. (EYPT) reported quick ratio of 6.6× in Q1 2026.
How has EyePoint, Inc. 's quick ratio changed year-over-year?
EyePoint, Inc. 's quick ratio decreased by 15.0% year-over-year, from 7.8× to 6.6×.
What is the long-term trend for EyePoint, Inc. 's quick ratio?
Over 5 years (2020 to 2025), EyePoint, Inc. 's quick ratio has grown at a 17.9% compound annual growth rate (CAGR), from 3.9× to 8.8×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.